Mauro M - Search Results

1

Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials.

Jabbour E, Apperley J, Cortes J, Rea D, Deininger M, Abruzzese E, Chuah C, DeAngelo DJ, Hochhaus A, Lipton JH, Mauro M, Nicolini F, Pinilla-Ibarz J, Rosti G, Rousselot P, Shah NP, Talpaz M, Vorog A, Ren X, Kantarjian H. Jabbour E, et al. Among authors: mauro m. Leukemia. 2024 Mar;38(3):475-481. doi: 10.1038/s41375-024-02159-0. Epub 2024 Jan 29. Leukemia. 2024. PMID: 38287132 Free PMC article.

2

Ph-positive and -negative myeloproliferative syndromes may co-exist.

Mauro MJ, Loriaux M, Deininger MW. Mauro MJ, et al. Leukemia. 2004 Jul;18(7):1305-7. doi: 10.1038/sj.leu.2403375. Leukemia. 2004. PMID: 15103389 No abstract available.

3

Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment.

Tefferi A, Dewald GW, Litzow ML, Cortes J, Mauro MJ, Talpaz M, Kantarjian HM. Tefferi A, et al. Among authors: mauro mj. Mayo Clin Proc. 2005 Mar;80(3):390-402. doi: 10.4065/80.3.390. Mayo Clin Proc. 2005. PMID: 15757021 Review.

4

Chronic myeloid leukemia in 2006: a perspective.

Mauro MJ, Deininger MW. Mauro MJ, et al. Haematologica. 2006 Feb;91(2):152. Haematologica. 2006. PMID: 16461297 Review. No abstract available.

5

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib.

Sherbenou DW, Wong MJ, Humayun A, McGreevey LS, Harrell P, Yang R, Mauro M, Heinrich MC, Press RD, Druker BJ, Deininger MW. Sherbenou DW, et al. Among authors: mauro m. Leukemia. 2007 Mar;21(3):489-93. doi: 10.1038/sj.leu.2404554. Epub 2007 Jan 25. Leukemia. 2007. PMID: 17252009

6

An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy.

Laudadio J, Deininger MW, Mauro MJ, Druker BJ, Press RD. Laudadio J, et al. J Mol Diagn. 2008 Mar;10(2):177-80. doi: 10.2353/jmoldx.2008.070128. Epub 2008 Feb 14. J Mol Diagn. 2008. PMID: 18276770 Free PMC article.

7

An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia.

Agarwal A, Eide CA, Harlow A, Corbin AS, Mauro MJ, Druker BJ, Corless CL, Heinrich MC, Deininger MW. Agarwal A, et al. Among authors: mauro mj. Leukemia. 2008 Dec;22(12):2269-72. doi: 10.1038/leu.2008.124. Epub 2008 May 29. Leukemia. 2008. PMID: 18509354 No abstract available.

8

Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib.

Press RD, Willis SG, Laudadio J, Mauro MJ, Deininger MW. Press RD, et al. Blood. 2009 Sep 24;114(13):2598-605. doi: 10.1182/blood-2008-08-173674. Epub 2009 Jul 22. Blood. 2009. PMID: 19625707 Free PMC article.

9

Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation.

Nicolini FE, Mauro MJ, Martinelli G, Kim DW, Soverini S, Müller MC, Hochhaus A, Cortes J, Chuah C, Dufva IH, Apperley JF, Yagasaki F, Pearson JD, Peter S, Sanz Rodriguez C, Preudhomme C, Giles F, Goldman JM, Zhou W. Nicolini FE, et al. Among authors: mauro mj. Blood. 2009 Dec 17;114(26):5271-8. doi: 10.1182/blood-2009-04-219410. Epub 2009 Oct 20. Blood. 2009. PMID: 19843886 Free PMC article.

10

Management of drug toxicities in chronic myeloid leukaemia.

Mauro MJ, Deininger MW. Mauro MJ, et al. Best Pract Res Clin Haematol. 2009 Sep;22(3):409-29. doi: 10.1016/j.beha.2009.06.001. Best Pract Res Clin Haematol. 2009. PMID: 19959091 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,339 results

Search Page

Filters